Marwan Ghosn - Concepedia

Author

Marwan Ghosn

Hôtel-Dieu de France ORCID

Also Known As

H.M. Oosterkamp, M Ghosn, M. G. Ghosn, M. GHOSN, M. Ghosn, Marwan Ghosn, Marwan G Ghosn, Marwan G. Ghosn, Marwan Ghosn

205

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Hôtel-Dieu de France Saint Joseph University American University of Beirut Medical Center Hammoud Hospital University Medical Center Cairo University

About

Marwan Ghosn is an author at Hôtel-Dieu de France specializing in medicine, oncology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	26	763
2	Health Sciences	3	3	67
3	Nursing	3	3	56
4	Public Health	3	3	89
5	Cell Biology	2	2	29

Marwan Ghosn

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non–Small Cell Lung Cancer (NSCLC) Byoung Chul Cho, Dong‐Wan Kim, Alessandra Bearz, Journal of Thoracic Oncology Fasted StateRandomized Phase 1MedicineMetronomic TherapyPharmacology	2017	169
Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1 Pramod K. Mistry, Elena Lukina, Hadhami Ben Turkia, JAMA	2015	152
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) Thomas Bachelot, Eva Ciruelos, Fabio Puglisi, Annals of Oncology Metastatic Breast CancerBreast OncologyMedicinePathologyPreliminary Safety	2019	111
Outcomes after 18 months of eliglustat therapy in treatment‐naïve adults with <scp>G</scp>aucher disease type 1: The phase 3 ENGAGE trial Pramod K. Mistry, Elena Lukina, Hadhami Ben Turkia, American Journal of Hematology	2017	96
FOLFOX-6 Combination as the First-Line Treatment of Locally Advanced and/or Metastatic Pancreatic Cancer Marwan Ghosn, Fadi Farhat, Joseph Kattan, American Journal of Clinical Oncology	2007	64
Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998 Ali Shamseddine, Abla Mehio Sibai, Nageeb Gehchan, Annals of Epidemiology EpidemiologyCancer EpidemiologyMedicineEpidemiology Of CancerPostwar Lebanon	2004	62
Perceptions of the COVID-19 vaccine Among Patients With Cancer: A Single-Institution Survey Elissar Moujaess, Naji Bou Zeid, Ramy Samaha, Future Oncology	2021	41
Clinical outcomes after 4.5 years of eliglustat therapy for <scp>Gaucher</scp> disease type 1: Phase 3 <scp>ENGAGE</scp> trial final results Pramod K. Mistry, Elena Lukina, Hadhami Ben Turkia, American Journal of Hematology	2021	40
Abridged geriatric assessment is a better predictor of overall survival than the Karnofsky Performance Scale and Physical Performance Test in elderly patients with cancer Marwan Ghosn, Tony Ibrahim, Elie Rassy, Journal of Geriatric Oncology NursingGeriatric OncologyAgingElderly PatientsGeriatrics	2016	35
Gemcitabine plus Carboplatin Combination Therapy as Second-Line Treatment in Patients with Relapsed Breast Cancer Fady Nasr, G. Chahine, Joseph Kattan, Clinical Breast Cancer Second-line TreatmentCarboplatin Combination TherapyBreast OncologyRelapsed Breast CancerMedicine	2004	34

Page 1